These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 6484205)
1. Therapeutic potential for blood-brain barrier modification in malignant brain tumor. Neuwelt EA Prog Exp Tumor Res; 1984; 28():51-66. PubMed ID: 6484205 [No Abstract] [Full Text] [Related]
2. Modification of the blood-brain barrier in the chemotherapy of malignant brain tumors. Neuwelt EA; Rapoport SI Fed Proc; 1984 Feb; 43(2):214-9. PubMed ID: 6692941 [TBL] [Abstract][Full Text] [Related]
3. Inability of dimethyl sulfoxide to increase brain uptake of water-soluble compounds: implications to chemotherapy for brain tumors. Greig NH; Sweeney DJ; Rapoport SI Cancer Treat Rep; 1985 Mar; 69(3):305-12. PubMed ID: 3978658 [TBL] [Abstract][Full Text] [Related]
4. Inability of dimethyl sulfoxide and 5-fluorouracil to open the blood-brain barrier. Neuwelt EA; Barnett P; Barranger J; McCormick C; Pagel M; Frenkel E Neurosurgery; 1983 Jan; 12(1):29-34. PubMed ID: 6219298 [TBL] [Abstract][Full Text] [Related]
5. Osmotic blood-brain barrier disruption: pharmacodynamic studies in dogs and a clinical phase I trial in patients with malignant brain tumors. Neuwelt EA; Hill SA; Frenkel EP; Diehl JT; Maravilla KR; Vu LH; Clark WK; Rapoport SI; Barnett PA; Lewis SE; Ehle AL; Beyer CW Cancer Treat Rep; 1981; 65 Suppl 2():39-43. PubMed ID: 6809316 [TBL] [Abstract][Full Text] [Related]
6. CT monitoring of chemotherapeutic agent delivery after osmotic blood brain barrier disruption. Neuwelt EA Clin Neurosurg; 1981; 28():520-31. PubMed ID: 6895614 [No Abstract] [Full Text] [Related]
7. [Chemotherapy in brain tumors]. van den Bent MJ; Schellens JH; Sillevis Smitt PA; Vecht CJ Ned Tijdschr Geneeskd; 1996 Mar; 140(13):702-6. PubMed ID: 8668248 [No Abstract] [Full Text] [Related]
8. Blood brain barrier modification and chemotherapy. Interventional neuroradiology in the treatment of malignant gliomas. Heimberger K; Samec P; Binder H; Podreka I; Reisner T; Deecke L; Horaczek A; Dittrich C; Steger G; Zimpfer M Acta Radiol Suppl; 1986; 369():223-6. PubMed ID: 2980457 [TBL] [Abstract][Full Text] [Related]
9. Enhancement of ketoconazole penetration across the blood-brain barrier of mice by dimethyl sulfoxide. Iwen PC; Miller NG Antimicrob Agents Chemother; 1986 Oct; 30(4):617-8. PubMed ID: 3789696 [TBL] [Abstract][Full Text] [Related]
10. The use of dimethyl sulfoxide to reversibly open the blood-brain barrier to protein. Salcman M; Broadwell R; Kaplan R; Egorin M Neurosurgery; 1983 Feb; 12(2):251. PubMed ID: 6835511 [No Abstract] [Full Text] [Related]
11. Intra-arterial chemotherapy following blood-brain barrier disruption in a patient with malignant glioma. Hill SA; Neuwelt EA J Neurosurg Nurs; 1982 Apr; 14(2):94-7. PubMed ID: 6811704 [No Abstract] [Full Text] [Related]
16. Monitoring of methotrexate delivery in patients with malignant brain tumors after osmotic blood-brain barrier disruption. Neuwelt EA; Diehl JT; Vu LH; Hill SA; Michael AJ; Frenkel EP Ann Intern Med; 1981 Apr; 94(4 pt 1):449-54. PubMed ID: 6782926 [TBL] [Abstract][Full Text] [Related]
17. Morphologic effect of dimethyl sulfoxide on the blood-brain barrier. Broadwell RD; Salcman M; Kaplan RS Science; 1982 Jul; 217(4555):164-6. PubMed ID: 7089551 [TBL] [Abstract][Full Text] [Related]
18. Pharmacology and toxicity of intracarotid adriamycin administration following osmotic blood-brain barrier modification. Neuwelt EA; Pagel M; Barnett P; Glassberg M; Frenkel EP Cancer Res; 1981 Nov; 41(11 Pt 1):4466-70. PubMed ID: 6796261 [TBL] [Abstract][Full Text] [Related]
19. Reversible osmotic blood-brain barrier disruption in humans: implications for the chemotherapy of malignant brain tumors. Neuwelt EA; Frenkel EP; Diehl J; Vu LH; Rapoport S; Hill S Neurosurgery; 1980 Jul; 7(1):44-52. PubMed ID: 6251399 [TBL] [Abstract][Full Text] [Related]